FIELD: medicine, ophthalmology. SUBSTANCE: the known medium containing medium-199 and dextran has additionally medium "Ф"-10, Dulbecko-Eagle medium, chondroitin sulfate, gentamycin sulfate, amphothericin B at the following ratio of components, wt.-%: medium M-199 25; medium "Ф"-10 25; chondroitin sulfate 2.7; dextran-40 2.0; gentamycin sulfate 0.00014; amphothericin B 0.00015, and medium Dulbecko-Eagle - the rest. EFFECT: improved transplantability and viability of endothelium.
Title | Year | Author | Number |
---|---|---|---|
PRESERVING AGENT FOR DONOR CORNEA | 2010 |
|
RU2450515C1 |
MEANS FOR PRESERVATION OF THE POSTERIOR LAYER TRANSPLANT OF THE DONOR CORNEA | 2018 |
|
RU2676311C1 |
MEANS FOR ORGANOTYPIC PRESERVATION OF DONOR CORNEA | 2020 |
|
RU2745114C1 |
AGENT FOR PRESERVATION OF DONOR CORNEA | 2017 |
|
RU2674585C1 |
METHOD OF PROCESSING HUMAN CADAVERIC KERATODERMA PRECEDING KERATOPLASTY | 2008 |
|
RU2381649C1 |
METHOD FOR DONOR CORNEA PROCESSING WITH DOUBLE-SIDED UV CROSSLINKING FOR KERATOPROSTHETICS OF COMPLICATED VASCULAR LEUCOMAS OF CATEGORY 4-5 | 2016 |
|
RU2613442C1 |
UNIVERSAL REMEDY FOR HYPOTHERMIC PRESERVATION OF CORNEA GRAFT | 2019 |
|
RU2710167C1 |
CORNEA STORAGE SOLUTION | 2012 |
|
RU2498570C1 |
MEDIUM FOR CONSERVATION AND FIXATION OF DONOR CORNEA WITH SUPPORTING ELEMENT OF KERATOPROSTHESIS | 1995 |
|
RU2098958C1 |
COMBINED METHOD FOR THE TREATMENT OF CORNEAL DISEASES WITH THE USE OF KERATOPLASTY AND CROSS-LINKING | 2017 |
|
RU2676434C1 |
Authors
Dates
1996-12-10—Published
1993-02-26—Filed